Two-visit cumulative HbA1c–adiposity exposure and incident cardiovascular disease in Chinese adults: a prospective community-based cohort study

Background Hyperglycemia and excess adiposity are closely related cardiovascular risk factors. We examined the associations of cumulative HbA1c and HbA1c–adiposity products measured over three years with subsequent cardiovascular disease (CVD) in Chinese adults. Methods This prospective study included 4,440 participants from the Dalian subcohort of the China Cardiometabolic Disease and Cancer Cohort Study who attended examinations in 2011 and 2014 and were free of CVD in 2014. Cumulative exposures were calculated from the two measurements of HbA1c, five adiposity indices and their products. Follow-up began in 2014. Multivariable Cox models, restricted cubic splines (RCS), joint exposure categories and sensitivity analyses were used to assess the associations. We also compared the products with their individual components and examined seven-year prediction performance. Results During a median follow-up of 7.21 years, 571 participants developed CVD. The adjusted hazard ratio (HR) per standard deviation increase was 1.13 (95% confidence interval [CI] 1.04–1.22) for cumulative HbA1c and 1.15–1.17 for the five cumulative products. These associations remained significant after false discovery rate correction. Participants with both high cumulative HbA1c and high cumulative adiposity had HRs of 1.36–1.51 compared with those with low levels of both. RCS analyses showed an overall increase in CVD risk at higher exposure levels, without evidence of nonlinearity. Incremental prediction gains were small. Conclusions Higher cumulative HbA1c–adiposity products were associated with subsequent CVD, and participants with high levels of both components had higher risk. These measures may help describe joint glycemic and adiposity exposure in cohort studies. A clear predictive advantage over models containing both components separately was not demonstrated, and clinical utility remains to be established.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-19
DOI
https://doi.org/10.3389/fendo.2026.1985370
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Two-visit cumulative HbA1c–adiposity exposure and incident cardiovascular disease in Chinese adults: a prospective community-based cohort study

Hao GuoHua, X. Liu, 谷晓岚, 秦俊嫄 et al.
Frontiers in Endocrinology
Diabetes, Cardiovascular Risks, and Lipoproteins
article

Two-visit cumulative HbA1c–adiposity exposure and incident cardiovascular disease in Chinese adults: a prospective community-based cohort study

Hao GuoHua, X. Liu, 谷晓岚, 秦俊嫄, Shen Li, Lan Luo, Yingzhuo Dong, Jia Li, Zhengnan Gao, Wei Zhao, Xinyu Li
article en

Abstract

Background Hyperglycemia and excess adiposity are closely related cardiovascular risk factors. We examined the associations of cumulative HbA1c and HbA1c–adiposity products measured over three years with subsequent cardiovascular disease (CVD) in Chinese adults. Methods This prospective study included 4,440 participants from the Dalian subcohort of the China Cardiometabolic Disease and Cancer Cohort Study who attended examinations in 2011 and 2014 and were free of CVD in 2014. Cumulative exposures were calculated from the two measurements of HbA1c, five adiposity indices and their products. Follow-up began in 2014. Multivariable Cox models, restricted cubic splines (RCS), joint exposure categories and sensitivity analyses were used to assess the associations. We also compared the products with their individual components and examined seven-year prediction performance. Results During a median follow-up of 7.21 years, 571 participants developed CVD. The adjusted hazard ratio (HR) per standard deviation increase was 1.13 (95% confidence interval [CI] 1.04–1.22) for cumulative HbA1c and 1.15–1.17 for the five cumulative products. These associations remained significant after false discovery rate correction. Participants with both high cumulative HbA1c and high cumulative adiposity had HRs of 1.36–1.51 compared with those with low levels of both. RCS analyses showed an overall increase in CVD risk at higher exposure levels, without evidence of nonlinearity. Incremental prediction gains were small. Conclusions Higher cumulative HbA1c–adiposity products were associated with subsequent CVD, and participants with high levels of both components had higher risk. These measures may help describe joint glycemic and adiposity exposure in cohort studies. A clear predictive advantage over models containing both components separately was not demonstrated, and clinical utility remains to be established.

Frontiers in EndocrinologyVol. 17
Dalian Medical University (CN), Dalian University of Technology (CN), Dalian University (CN), Dalian Municipal Central Hospital (CN), Affiliated Zhongshan Hospital of Dalian University (CN)
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon